Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues

This study evaluated the predictive value of serum HBV DNA, HBV RNA, HBcrAg, HBsAg, intrahepatic HBV DNA and cccDNA for HBeAg clearance and seroconversion during long‐term treatment with nucleos(t)ide analogues (NAs) in patients with chronic hepatitis B (CHB). A single centre, prospective cohort of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yang, Liao, Hao, Deng, Zhongping, Liu, Yanna, Bian, Dandan, Ren, Yan, Yu, Guangxin, Jiang, Yingying, Bai, Li, Liu, Shuang, Liu, Mei, Zhou, Li, Chen, Yu, Duan, Zhongping, Lu, Fengmin, Zheng, Sujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311425/
https://www.ncbi.nlm.nih.gov/pubmed/35274400
http://dx.doi.org/10.1111/jvh.13671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311425/
https://www.ncbi.nlm.nih.gov/pubmed/35274400
http://dx.doi.org/10.1111/jvh.13671

Ejemplares similares